1. NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms.

    Oncotarget 7(3):3018 (2016) PMID 26689988 PMCID PMC4823087

    NDN is a maternally imprinted gene consistently expressed in normal ovarian epithelium, is dramatically downregulated in the majority of ovarian cancers. Little or no NDN expression could be detected in 73% of 351 epithelial ovarian cancers. NDN was also downregulated in 10 ovarian cancer cell l...
  2. Verteporfin inhibits YAP function through up-regulating 14-3-3σ sequestering YAP in the cytoplasm.

    American journal of cancer research 6(1):27 (2016) PMID 27073720 PMCID PMC4759394

    Yes-associated protein (YAP), the central mediator of Hippo pathway, not only regulates a diversity of cellular processes during development but also plays a pivotal role in tumorigenesis. YAP is overexpressed in many types of human cancers with its expression level being associated with patient...
  3. ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathway.

    Tumor Biology 36(3):1529 (2015) PMID 25608836

    The purpose of the study was to explore the role and mechanism of ataxia-telangiectasia mutated (ATM) protein in endometrial carcinogenesis. A reverse-phase protein array (RPPA) was used to analyze the expression of ATM signal pathway proteins in Ishikawa and progesterone-insensitive Ishikawa. A...
  4. Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma.

    Epigenetics 8(12):1330 (2013) PMID 24135786 PMCID PMC3933493

    The initiation of angiogenesis can mark the transition from tumor dormancy to active growth and recurrence. Mechanisms that regulate recurrence in human cancers are poorly understood, in part because of the absence of relevant models. The induction of ARHI (DIRAS3) induces dormancy and autophagy...
  5. Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN/PI3K/AKT signaling pathway.

    Cancer Letters 339(2):279 (2013) PMID 23142288

    Gankyrin has been implicated in the formation of multiple cancer types, although its roles in estrogen-driven endometrial carcinoma remain unclarified. We evaluated the expression of Gankyrin in endometrial tissues and further explored its roles in estrogen-driven and GPR30-mediated endometrial ...
  6. Corilagin inhibits hepatocellular carcinoma cell proliferation by inducing G2/M phase arrest.

    Cell Biology International 37(10):1046 (2013) PMID 23686743

    Hepatocellular carcinoma (HCC) is one of most common types of malignant tumours. Therefore, it is very important to identify powerful drugs and their antitumour mechanisms. Corilagin has a significant antitumour potential and lower toxicity in normal cells in vitro. The IC50 values of corilagin ...
  7. Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway.

    International Journal of Oncology 43(4):1194 (2013) PMID 23921511 PMCID PMC3981007

    OCT4, a stem cell marker, is overexpressed in several types of human cancer and can induce resistance to chemotherapy and inhibition of apoptosis. We previously demonstrated that human follicle stimulating hormone (FSH) can inhibit ovarian cancer cell apoptosis. However, the role of OCT4 in FSH-...
  8. FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3.

    Endocrine-Related Cancer 20(3):415 (2013) PMID 23580589 PMCID PMC3669658

    Recent studies have suggested that FSH plays an important role in ovarian epithelial carcinogenesis. We demonstrated that FSH stimulates the proliferation and invasion of ovarian cancer cells, inhibits apoptosis and facilitates neovascularisation. Our previous work has shown that transient recep...
  9. Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma.

    Histopathology 62(5):675 (2013) PMID 23425310

    Endometrial stromal sarcoma (ESS) has traditionally been divided into low and high grade, but the World Health Organization (WHO, 2003) has changed the definition. Since 2003, many studies have used the old criteria, and few have focused on WHO 2003-defined ESS low grade (ESS-LG). The aim of thi...
  10. A novel role of proteasomal β1 subunit in tumorigenesis.

    Bioscience Reports 33(4) (2013) PMID 23725357 PMCID PMC3712487

    p27Kip1 is a key cell-cycle regulator whose level is primarily regulated by the ubiquitin-proteasome degradation pathway. Its β1 subunit is one of seven β subunits that form the β-ring of the 20S proteasome, which is responsible for degradation of ubiquitinated proteins. We report here that the ...
  11. Huaier aqueous extract inhibits ovarian cancer cell motility via the AKT/GSK3β/β-catenin pathway.

    PLoS ONE 8(5):e63731 (2013) PMID 23667667 PMCID PMC3648479

    Traditional Chinese medicine has gained popularity due to its ability to kill tumor cells. Recently, the apoptotic and anti-angiogenic effects of Trametes robiniophila murr (Huaier) have been investigated. The aim of this study was to investigate its effect on cell mobility and tumor growth in o...
  12. A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways.

    BMC Complementary and Alternative Medicine 13:33 (2013) PMID 23410205 PMCID PMC3598193

    Phyllanthus niruri L. is a well-known hepatoprotective and antiviral medicinal herb. Recently, we identified Corilagin as a major active component with anti-tumor activity in this herbal medicine. Corilagin is a member of the tannin family that has been discovered in many medicinal plants and ha...
  13. Knockdown of RAB25 promotes autophagy and inhibits cell growth in ovarian cancer cells.

    Molecular Medicine Reports 6(5):1006 (2012) PMID 22940905

    RAB25 belongs to the Rab family of small GTPases and is implicated in the development of various types of human cancer. To evaluate the role of RAB25 in ovarian cancer, RAB25 was knocked down by siRNA in HEY and ES‑2 human ovarian cancer cells. Autophagy, cell...
  14. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer.

    Journal of Clinical Investigation 122(4):1469 (2012) PMID 22406531 PMCID PMC3314447

    Breast cancers are highly heterogeneous but can be grouped into subtypes based on several criteria, including level of expression of certain markers. Claudin-low breast cancer (CLBC) is associated with early metastasis and resistance to chemotherapy, while gene profiling indicates it is characte...
  15. Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome.

    BMC Cancer 12:243 (2012) PMID 22695491 PMCID PMC3476972

    Aberrant promoter CpG island hypermethylation is associated with transcriptional silencing. Tumor suppressor genes are the key targets of hypermethylation in breast cancer and therefore may lead to malignancy by deregulation of cell growth and division. Our previous pilot study with pairs of mal...
  16. Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.

    Molecular Medicine 18:1197 (2012) PMID 22801793 PMCID PMC3510297

    Ovarian cancers are heterogeneous and contain stemlike cells that are able to self-renew and are responsible for sustained tumor growth. Metastasis in the peritoneal cavity occurs more frequently in ovarian cancer than in other malignancies, but the underlying mechanism remains largely unknown. ...
  17. Re-expression of estrogen receptor β inhibits the proliferation and migration of ovarian clear cell adenocarcinoma cells.

    Oncology Reports 26(6):1497 (2011) PMID 21874257

    Ovarian clear cell adenocarcinoma (OCCA) is an aggressive ovarian malignancy with a poor prognosis. The role of estrogen receptor β (ERβ) in the development of OCCA remains to be clarified. To investigate the action of ERβ in the proliferation and invasion of ...
  18. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.

    Cancer 117(19):4424 (2011) PMID 21491416 PMCID PMC3137708

    Epigenetic therapy has had a significant impact on the management of hematologic malignancies, but its role in the treatment of ovarian cancer remains to be defined. The authors previously demonstrated that treatment of ovarian and breast cancer cells with DNA methyltransferase and histone deace...
  19. Luteinizing hormone upregulates survivin and inhibits apoptosis in ovarian epithelial tumors.

    European Journal of Obstetrics & Gynecology and... 155(1):69 (2011) PMID 21074309

    Luteinizing hormone (LH) plays an important role in the development of ovarian cancer, and has been shown to inhibit apoptosis in ovarian cancer cells. Similarly, survivin is a molecule that has been shown to inhibit apoptosis in other types of cancer. Therefore, the aim of this study was to det...
  20. Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer.

    Cancer Science 102(3):557 (2011) PMID 21205080

    Progestin resistance is the main obstacle to successful conservative therapy in young endometrial cancer patients. To investigate the molecular events that lead to progestin resistance and to find a possible way to reverse progestin resistance in endometrial cancer, we established a progestin-re...